(R)-tert-Butyl 3-((4,6-dimethylpyrimidin-2-yl)oxy)pyrrolidine-1-carboxylate

Catalog No. :
ACLFDE061
CAS No. :
1261234-28-9
Molecular Formula :
C15H23N3O3
Molecular Weight :
293.37

IUPAC Name:tert-butyl (R)-3-((4,6-dimethylpyrimidin-2-yl)oxy)pyrrolidine-1-carboxylate

(R)-tert-Butyl 3-((4,6-dimethylpyrimidin-2-yl)oxy)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$592.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl 3-((4,6-dimethylpyrimidin-2-yl)oxy)pyrrolidine-1-carboxylate
IUPAC Nametert-butyl (R)-3-((4,6-dimethylpyrimidin-2-yl)oxy)pyrrolidine-1-carboxylate
MDL No.MFCD18380169
Molecular FormulaC15H23N3O3
Molecular Weight293.37
SMILESO=C(N1C[C@H](OC2=NC(C)=CC(C)=N2)CC1)OC(C)(C)C
InChI KeyXVQCPNYVMHAVEQ-GFCCVEGCSA-N
Synonym(R)-3-(4,6-Dimethyl-pyrimidin-2-yloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester
CAS No.1261234-28-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLFDE061 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEIGP018 route compound structure diagram
    ACEIGP018109431-87-0 In Stock
  2. Plus
  3. ACMALW908 route compound structure diagram
    ACMALW9084472-44-0 In Stock
  4. Then
  5. ACLFDE061 route product structure diagram
    ACLFDE0611261234-28-9
Inquiry

2. ACLFDE061 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEIGP018 route compound structure diagram
    ACEIGP018109431-87-0 In Stock
  2. Plus
  3. ACLORX935 route compound structure diagram
    ACLORX93516879-39-3 In Stock
  4. Then
  5. ACLFDE061 route product structure diagram
    ACLFDE0611261234-28-9
Inquiry

Comments (0)